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In March, 1964, Greiner and Berry (1) de-
scribed in detail their observations of 70 pa-
tients with abnormal oculocutaneous pig-
mentation following long-term, high dose
chlorpromazine therapy. They first noted this
phenomenon in 1958. Several common factors
were found in most patients; the majority
were Caucasians with very fair skin, and had
histories of prolonged sunlight exposure. Most
of the patients were females and all of these were
amenorrheic. The principal neuropsychiatric
disorders for which the drug was given were
schizophrenia and mental deficiency. All pa-
tients had received very large, daily doses of
chlorpromazine. Other authors have subse-
quently reported similar findings (2—7). The
object of the present work was to attempt
to reproduce the oculocutaneous pigmentation
in the guinea pig. Once a suitable experimental
technic was developed, it was hoped to elucidate
the cause of the pigmentary defect and if
possible the exact chemical nature of the pigment.
MATERIALS AND METHODS
Eighty-three mature guinea pigs were used and
they were divided into groups as follows:
Group I consisted of 18 albino, 6 pure red and 6
pure black animals. Control skin biopsy specimens
were taken from closely sheared areas on the an-
t2rior abdominal wall of each animal. The ani-
mals were then given 40 mg of eblorpromazine
daily by mouth for 6 months. This dose was
chosen since it closely approximated or exceeded
per kilogram the daily dose of the drug given to
humans. The closely sheared abdomen was exposed
to ultraviolet light for twenty minutes daily using
a technic described previously (8). A Sylvania forty
watt fluorescent bulb with a peak output at 3,200
A, placed thirty inches above each animal, was
i'sed as a light source. At the end of 3 and 6
months skin biopsy specimens were taken of the
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light exposed areas. All the biopsy specimens were
fixed in 10% formal saline solution and imbedded
in paraffin. Six micron thick vertical sections were
cut, and unstained sections, sections stained with
hematoxylin and eosin, and eosin alone were ex-
amined mieroscopically.t Three of the twelve pig-
mented animals; 2 red and 1 black were sub-
mitted to total autopsy examination. Sections of
the liver, spleen and heart were examined micro-
scopically.
Group II consisted of 12 male albino guinea
pigs. Each animal was injected intradermally in
four abdominal quadrants with a single dose—0.1
ml of an aqueous solution of pure chlorpromazine.
0.5 mgm/ml of chlorpromazine was chosen as a
suitable dose for intradermal injections since
larger concentrations had been found to be ex-
tremely irritating to the skin, often causing tissue
necrosis. In order to study the combined local
effect of chlorpromazine and ultraviolet ligbt the
injection sites of six of the animals were exposed
to a light source of 3,200—3,600 A each day for 10
days. One other animal was injected with chlor-
promazine intradermally after the drug had been
exposed to ultraviolet light for 20 minutes. At in-
tervals varying from 7—11 days following the in-jection, skin biopsy specimens were taken and
processed as described previously.
Group III consisted of thirty-six guinea pigs
equally divided among males and females; red,
black and albinos were used. Control skin biopsy
specimens were taken from the closely sheared
backs of each animal. All guinea pigs were then
continuously exposed to an ultraviolet source
placed 10 inches above their backs. It was de-
cided to use a source of ultraviolet light which
had a peak emanation frequency around 3600 A
since this frequency approximated the ultraviolet
activation spectrum for the various forms of
chlorpromazine. Because this part of the experi-
ment was to extend over a prolonged period of
time and it was desirable to have the minimum
number of animal deaths from drug toxicity, the
dose of chlorpromazine was reduced to 30 mgm/
day. The drug was given for a 12 month period
except for an interval of 2 weeks during the sixth
month. The animals were sheared twice weekly
to ensure that the dorsal skin was adequately ex-
posed to the ultraviolet light source. Skin biopsy
specimens were taken at 3, 6, 9 and 12 month in-
tervals and processed as above.
t Haag-Streit slit lamp examination of both eyes
of the surviving animals were performed 1—3
months after cessation of the chlorpromazine
therapy.
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Group IV consisted of one albino, two red, and
two black male guinea pigs. Tbey were injected
intraperitoneally with an aqueous solution of 5"
labeled chlorpromazine having an activity of 4
microcuries per injection. Skin biopsy specimens
were taken at one, three, fourteen and twenty-one
days. Biopsy specimens also were taken of the
liver, spleen and heart when the animals were
sacrificed on the 21st day. Stained autoradio-
graphs were made of 6 sections according to the
procedure outhncd by Joftes (9).
RESULTS
Group I
Macroscopic examination—At the start of
the experiment, erythema followed by scaling,
without blister forniation was evident on the
U.V. light exposed areas in the albino and the
very light red animals but tended to fade as
the experiment progressed. Both the red and
black animals showed a marked increase in
pigmentation of the irradiated areas.t
Microscopic examination—In all the ani-
mals the stratum corneum was thickened. In
the red and black animals the pigment was in-
creased throughout the epidermis, but it was
no greater than the increased melanin pigmen-
tation which occurs after prolonged ultraviolet
light exposure (5). No pigment was observed
in the dermis, and no pigment deposits were
noted in the visceral organs.
Group 11
Macroscopic examination .—Each injection
site of the chlorpromazinc solution became ery-
thematous and edematous but no ulceration oc-
curred.
Microscopic examination.—All sections ex-
amined showed no evidence of dermal pigment
deposits.
Group III
Macroscopic examination—A marked in-
crease in skin pigmentation was noted in the
black and darker red animals within 1—2 weeks
after initiation of ultraviolet exposure; the
degree of pigmentation was similar to that
found in the animals of group I.
All of the albino animals and several of the
light red animals had severe crythema and bhs-
tcr formatiou on the skin of the backs and ears
t We wish to thank Dr. Rufus Howard of the
Department of Surgery, Yale University School
of Medicine for examining the guinea-pig eyes.
for the first seven days of the experiment. This
reaction subsequently subsided without pig-
ment formation. However, when the ehlorpro-
mazthe therapy was resumed after two weeks
cessation during the sixth month of treatment
the skin reaction recurred.
Microscopic examination.—Thickening of the
epidermis was evident in all the animals in
this group. Increased epidermal pigment was
observed in the red ancL black animals sim-
ilar to that described in group 1. Again no der-
mal deposits of pigment were noted (Fig. 1).
Slit lamp examination—At a magnification
of x16 the eyes of every animal were found to
have lens opacities. The most frequent lesion
was a veil-like opacity arranged in a geo-
graphic pattern (Fig. 2) and composed of
small white dots. It was most commonly located
in the anterior subeapsular area. The second
most common site was the posterior cortex of
the lens. No changes were observed in the nu-
cleus, or associated with the suture lines of
the lens. This lenticular lesion was not seen in
any of the control animals of a similar age.
Group IV
S' labeled chiorpromazine was not detected
in any of the autoradiographic sections ex-
amined.
DiscussioN
Chlorpromazine has been used (1) to allevi-
ate the multiplicity of symptoms wInch arc
manifestations of mental disease; (2) as an
antiemetic; and (3) to potcntiate other central
nervous system depressants. A large number of
side effects have been attributed to the drug,
yet none has been sufficiently severe or fre-
quent enough to outweigh the therapeutic
benefits derived from its use. Until Greiner
and Berry described the pigmentary phenom-
ena associated with ehlorpromazine therapy,
the only dermatologieal reactions recorded in
the literature were of the photosensitivity type,
both photoallergie and phototoxie. Exfoliative
dermatitis had been reported infrequently.
Ghlorpromazine pigmentation in the human
subject gives a mild to pronounced, diffuse,
purplish-grey metallic discoloration to the ex-
posed skin surfaces. The exposed bulbar eon-
junctivae in patients with extensive skin pig-
mentation are usually brown in color. The
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FIG. 1. Photomicrograph of vertical sections of dorsal skin of black mature male guinea
pig (a) before treatment (b) after 12 months treatment with chlorpromazine and ultra-
violet light. Shows a marked increase in the amount of melanin present in all layers of the
epidermis especially in the basal layer. Note the complete absence of pigment in the
dermis. No stain, X 150.
Fro. 2. Photograph of the eye of a red guinea pig. (a) no treatment (b) after 12 months
treatment with chlorpromazine and ultraviolet light. Shows the veil-like lenticular opacity
arranged in a geographic pattern.
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difference in color of the pigment in the two re-
gions is an apparent one and is due to the dif-
ferent optical properties of the tissue in which
the pigment is located.
Histopathologically, the epidermis is normal.
Extensive deposits of finely granular, golden
brown pigment are seen in reticuloendothelial
cells in the upper third of the dermis. The
heavily laden cells usually lie in close proxim-
ity to capillaries. Silver stains of this material
are strongly positive, peroxide bleaches out the
pigment, and iron and fat stains have been
consistently negative. As a result of the above
reactions, Greiner and Berry and others felt
strongly that the pigment is melanin (1, 5, 10).
More recent studies by Zelickson and others
have shown that the pigment does not have the
same electron microscopic appearance as mela-
nin (11). The intraocular manifestations are
eorneal opacities which are made up of a yel-
low-white granular material and central, stel-
late lenticular opacities composed of yellow-
white granular material (12—14).
In the current experiments using the guinea
pig, attempts were made to simulate condi-
tions which were presumed necessary for the
production of abnormal pigmentation in the
human subject. Chlorpromazine was adminis-
tered in large doses over a long period of time,
and since cutaneous pigmentation only oc-
curred on exposed surfaces, the shaved animals
were subjected to continuous ultraviolet light.
A mild toxic dermatitis was demonstrated
when drug therapy was initiated and when it
was resumed after an interval of two weeks dur-
ing the sixth month of treatment but no der-
mal reaction was demonstrated. Although the
drug was continued for a total period of 12
months in one group of animals it is possible
that, in the guinea pig, chlorpromazine had to
be administered for a longer period of time to
produce recognizable skin changes. The ocular
findings on the other hand, closely resembled
those described previously in the human sub-
ject (12—14). Intraocular lesions are much more
prevalent than skin findings in humans, and it
is generally believed that ocular lesions pre-
cede the onset of skin lesions.
SUMMARY
(1) Large doses of chlorpromazine were ad-
ministered to albino, red and black guinea
pigs in an attempt to reproduce the abnormal
oeulocutaneous pigmentation reported in the
human subject.
(2) After giving the drug for a period of 12
months and exposing the shaved animals con-
tinuously to ultraviolet light, no dermal de-
posits of pigment were demonstrated.
(3) Slit lamp examination of the guinea pig
eyes following the drug treatment revealed lens
opacities in all the animals. These were com-
posed of small white dots located in the ante-
rior subcapsular area and also in the posterior
cortex of the lens. They were identical with
those reported in the human subject.
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